title: Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells.
abstract: Overexpression of human apolipoprotein A-II (hapo A-II) in transgenic mice (hAIItg mice) induced marked hypertriglyceridemia and low levels of plasma high density lipoprotein (HDL) with a high hapo A-II content. We sought to determine whether cholesterol efflux to plasma and HDL from these mice would be affected. In the Fu5AH cell system, plasma from hAIItg mice induced a markedly lower cholesterol efflux than did control plasma, in accordance with the dependence of efflux on HDL concentration. Moreover, HDLs from hAIItg mice were less effective acceptors than were control HDLs. In the J774 macrophage cell system, pretreatment with cAMP, which upregulates ATP binding cassette transporter 1, induced a marked increase in the efflux to hAIItg plasma as well as to purified hapo A-I and hapo A-II, whereas it had no effect on cholesterol efflux to control plasma. A strong positive correlation was established between percent cAMP stimulation of efflux and plasma hapo A-II concentration. The cAMP stimulation of efflux to hAIItg mouse plasma may be linked to the presence of pre-beta migrating HDL containing hapo A-II. Thus, despite lower HDL and apolipoprotein A-I contents, the increased ability of plasma from hAIItg mice to extract cholesterol from macrophage-like cells may have an antiatherogenic influence.
authors.affiliation: Laboratoire de Biochimie, Faculté des Sciences Pharmaceutiques, Châtenay-Malabry, France. natalie_fournier@yahoo.fr
authors.forename: Natalie
authors.initials: N
authors.lastname: Fournier
authors.forename: Anne
authors.initials: A
authors.lastname: Cogny
authors.forename: Véronique
authors.initials: V
authors.lastname: Atger
authors.forename: Danièle
authors.initials: D
authors.lastname: Pastier
authors.forename: Dominique
authors.initials: D
authors.lastname: Goudouneche
authors.forename: Antonino
authors.initials: A
authors.lastname: Nicoletti
authors.forename: Nicole
authors.initials: N
authors.lastname: Moatti
authors.forename: Jean
authors.initials: J
authors.lastname: Chambaz
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Paul
authors.forename: Athina-Despina
authors.initials: AD
authors.lastname: Kalopissis
mesh_terms: D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000818:Animals; D016632:Apolipoprotein A-I / Q000097:blood; D016633:Apolipoprotein A-II / Q000378:metabolism*; D002478:Cells, Cultured; D002784:Cholesterol / Q000097:blood*; D000242:Cyclic AMP / Q000494:pharmacology; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000209:etiology / Q000473:pathology*; D008075:Lipoproteins, HDL / Q000097:blood*; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic
chemical_list: D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D008075:Lipoproteins, HDL; D002784:Cholesterol; D000242:Cyclic AMP